# Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

> **NCT05634720** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Duke University** · enrollment: 20 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** HA Chemotherapy

## Key facts

- **NCT ID:** NCT05634720
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2025-11-18
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05634720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05634720, "Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05634720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*